Desmopressin (DDAVP) is an analog of vasopressin and is a potent agonist of the vasopressin-2 receptor (VR2) used in the management of diabetes insipidus, night enuresis, and hematological disorders (33). The gene discussed is VTRNA1-2; the disease is Central diabetes insipidus.